PharmaCieloPCLOF -4.35% Gross Margin % is 165.83% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 938 Drug Manufacturers companies, PharmaCielo ranks worse than 87.31% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. PharmaCielo's Gross Profit for the
three
months ended in Dec. 2025 was $0.73 Mil. PharmaCielo's Revenue for the
three
months ended in Dec. 2025 was $0.44 Mil. Therefore, PharmaCielo's Gross Margin % for the quarter that ended in Dec. 2025 was 165.83%.
The historical rank and industry rank for PharmaCielo's Gross Margin % or its related term are showing as below:
PCLOF'
s Gross Margin % Range Over the Past 10 Years
Min: -250.04 Med: -210.93 Max: 24.53
Current: 24.53
During the past 7 years, the highestGross Margin % of PharmaCielo was 24.53%. The lowest was -250.04%. And the median was -210.93%.
PCLOF's Gross Margin % is ranked worse than 87.31% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs PCLOF: 24.53
PharmaCielo had a gross margin of 165.83% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for PharmaCielo was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PharmaCielo had a gross margin of 165.83% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PharmaCielo Gross Margin % Related Terms
PharmaCielo Gross Margin % Historical Data
* Premium members only.
The historical data trend for PharmaCielo's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PharmaCielo's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCielo Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PharmaCielo's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PharmaCielo's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PharmaCielo (PCLOF) has a Gross Margin % of 165.83% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on PharmaCielo and its competitors. According to the industry distribution chart, PharmaCielo ranks #819 out of 938 companies in the Drug Manufacturers industry, placing it in the top 87.3%.
Is PharmaCielo's Gross Margin % too high?
PharmaCielo's current Gross Margin % is 165.83%. The Drug Manufacturers industry median Gross Margin % is 48.44. PharmaCielo's value of 165.83% is 242.3% above this industry median. Based on the distribution chart, PharmaCielo ranks #819 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does PharmaCielo's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, PharmaCielo ranks #819 out of 938 companies for Gross Margin %. This places PharmaCielo in the lower half of its industry. The industry median Gross Margin % is 48.44. PharmaCielo's value of 165.83% is 242.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCielo's current Gross Margin % of 165.83% is 242.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PharmaCielo and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCielo's current Gross Margin % is 165.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.05 — trading 48.5% below its estimated fair value. The current Gross Margin % is 165.83% and 242.3% above the Drug Manufacturers industry median of 48.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Gross Margin % is 165.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PCLOF has been successfully added to your 